Biobank Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product {Equipment (Cryogenic Storage System, Alarm Monitoring Systems, Others), Media & Consumables}, By Application (Regenerative Medicine, Drug Discovery, and Others), By Region and Competition 2019-2029F

Market Overview

The Global Biobank Equipment Market was valued at USD 47.25 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 5.75% through 2029. Biobank equipment refers to specialized storage and handling solutions for biological samples, including tissues, cells, DNA, and other biomolecules. These facilities serve as crucial repositories, providing researchers with access to a diverse range of specimens for various applications, such as drug discovery, genomics, and disease research.

One of the key drivers of this market is the rising prevalence of chronic diseases worldwide. This has propelled the demand for biobanks, which play a pivotal role in understanding the underlying genetic, environmental, and lifestyle factors contributing to these diseases. Additionally, the emergence of personalized medicine and genomic research is fueling the need for high-quality, well-preserved biological samples.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases has emerged as a significant driver in the growth of the biobank equipment market. With conditions like diabetes, cardiovascular diseases, and various forms of cancer becoming more widespread, there is an imperative need for comprehensive research and development efforts. Biobanks play a pivotal role in this process by providing a repository for storing and managing biological samples essential for understanding the underlying genetic, environmental, and lifestyle factors contributing to these diseases. This surge in demand for biobank facilities has led to a corresponding increase in the need for advanced equipment that can efficiently handle, store, and preserve these precious biological specimens. As a result, manufacturers and suppliers of biobank equipment are experiencing a substantial upswing in their market share, driven by the urgent requirement to combat the rising tide of chronic illnesses through rigorous scientific investigation and targeted therapies.

Increasing Biomedical Research

The expansion of biomedical research has emerged as a powerful catalyst for the growth of the biobank equipment market. As scientific advancements continue to unlock new avenues for understanding and treating various diseases, the demand for high-quality biological samples has surged. Biobanks serve as indispensable repositories for these critical specimens, providing a centralized and organized platform for researchers to access a diverse range of samples. This surge in demand has created a corresponding need for advanced equipment capable of efficiently processing, storing, and managing these biological resources. Manufacturers and suppliers of biobank equipment are thus experiencing a notable uptick in demand. Moreover, as the scope and complexity of biomedical research expand to encompass personalized medicine, genetic studies, and drug development, the importance of biobanks in facilitating these endeavors becomes increasingly apparent. Consequently, the market for biobank equipment is poised for sustained growth, driven by the escalating requirements of the burgeoning biomedical research community worldwide.

Download free Sample Report

Key Market Challenges

Ethical and Legal Issues

Biobanks must navigate a complex landscape of ethical considerations and legal requirements when collecting and storing biological samples. This includes obtaining informed consent from donors, which ensures that individuals are fully aware of how their samples will be used in research and have given their voluntary permission for it.

Additionally, biobanks must address privacy and confidentiality concerns. They need to implement measures to protect the identity and personal information of donors, ensuring that their data remains confidential and secure.

Another crucial aspect is determining ownership and usage rights of stored samples. This involves defining who has control over the samples and under what circumstances they can be used for research. This can be particularly challenging in cases where samples are donated for a specific study but may hold potential for other research projects in the future.

Sample Quality and Integrity

Biobanks are entrusted with the responsibility of preserving biological specimens, such as tissues, cells, and DNA, for potential use in research. However, over time, these samples can face various threats to their integrity. Factors like improper storage conditions, fluctuations in temperature, exposure to contaminants, and natural degradation processes can all compromise the quality of the samples.

To mitigate these risks, biobanks must implement stringent protocols for sample handling, storage, and monitoring. This includes using specialized equipment like ultra-low temperature freezers, cryogenic storage systems, and other advanced technologies to maintain the samples in optimal conditions. Regular monitoring and maintenance of equipment are essential to ensure consistent and reliable storage conditions.

Additionally, biobanks must have contingency plans in place to address potential emergencies or equipment failures that could jeopardize sample integrity. This may involve backup power systems, redundant storage facilities, and protocols for transferring samples in case of emergencies.

Quality control measures, such as periodic sample testing and validation, are also crucial for identifying and addressing any potential issues with sample quality. This helps ensure that the samples retain their integrity and viability for future research purposes.

Key Market Trends

Automation and Robotics Integration

Automation and robotics are being increasingly employed in biobanks to streamline and enhance various processes involved in sample management. This trend is driven by the desire to improve operational efficiency, reduce human error, and optimize resource utilization.

In practical terms, this trend involves the use of automated systems for tasks such as sample retrieval, tracking, labeling, and storage. Advanced robotic systems can handle samples with precision and accuracy, ensuring that they are stored and handled in optimal conditions. This not only minimizes the risk of contamination or degradation but also allows for more efficient use of storage space.

Furthermore, automation can facilitate high-throughput processing, enabling biobanks to handle larger volumes of samples more effectively. This is particularly crucial as the demand for biospecimens in research continues to grow.

Growing Role of Genomic Biobanks

Genomic biobanks focus primarily on the collection, storage, and management of genetic materials, such as DNA, RNA, and other genetic components. These biobanks play a pivotal role in supporting research initiatives that seek to understand and analyse the genetic basis of various diseases, as well as contribute to advancements in personalized medicine.

Genomic biobanks are particularly crucial in the era of genomics, where researchers are increasingly interested in studying the genetic variations that underlie diseases and impact individual responses to treatments. By storing genetic materials from a diverse range of donors, these biobanks provide a rich source of data for genetic studies and help accelerate discoveries in areas like disease susceptibility, drug development, and the development of targeted therapies.

The trend of focusing on genomic biobanking reflects a broader shift in the field of biobanking towards precision medicine. This approach tailor’s medical treatment and interventions to the individual characteristics of patients, including their genetic makeup. Genomic biobanks are at the forefront of this trend, supplying the genetic information needed for more personalized and effective healthcare solutions.

Segmental Insights

Application Insights

The Drug Discovery Segment dominates the Biobank Equipment market and is predicted to continue expanding over the coming years. The drug discovery segment is poised to dominate the global biobank equipment market due to its critical role in advancing pharmaceutical research and development. Biobanks serve as invaluable repositories of biological samples, providing researchers with access to a diverse range of specimens for drug testing and development. As the demand for novel and effective pharmaceutical compounds continues to surge, biobanks have become indispensable resources for the biopharmaceutical industry. These facilities store a wide array of biological materials, including tissues, cells, and genetic samples, which are essential for pre-clinical and clinical trials. 

Download free Sample Report

Regional Insights

The North America region has established itself as the leader in the Biobank Equipment Market in 2023 due to a combination of factors that make it a thriving hub for Biobank Equipment innovation and adoption. The North America region has emerged as the frontrunner in the Biobank Equipment Market in 2023, primarily due to a convergence of factors that position it as a dynamic centre for Biobank Equipment innovation and adoption. Firstly, North America boasts a robust and mature healthcare infrastructure, characterized by advanced research facilities, well-established biotechnology firms, and a highly skilled workforce. This environment fosters a conducive ecosystem for the development and deployment of cutting-edge biobank equipment.

Furthermore, the region is characterized by a strong emphasis on research and development, with substantial investments being made in biomedical sciences and pharmaceuticals. This commitment to scientific advancement drives the demand for state-of-the-art biobank equipment, which plays a pivotal role in facilitating ground-breaking research endeavours.

Recent Developments

• In February 2024, PHC Corporation of North America (PHCNA), a prominent supplier of the PHCbi brand's cell preservation and growth products in North America and Latin America, introduced a new addition to its PHCbi brand VIP ECO SMART ultra-low temperature (ULT) freezer series. The MDF-DU703VHA-PA stands out as the initial PHCbi brand ULT freezer to incorporate dual voltage capability, enabling laboratories in medical institutions, universities, and pharmaceutical companies to effortlessly transition between 115V and 220V power sources. This fresh model maintains the distinguished energy-saving performance and heightened security features characteristic of the VIP ECO SMART series.

Key Market Players

• Becton, Dickinson and Company
• Bio-Techne Corporation
• Hamilton Company
• Merck KgaA
• Lonza Group AG
• QIAGEN N.V.
• Stemcell Technologies Inc.
• Tecan Group AG
• Thermo Fisher Scientific Inc 

Report Scope:

In this report, the Global Biobank Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Biobank Equipment Market, Test Type:
• Equipment

• Cryogenic Storage System
• Alarm Monitoring Systems
• Others

• Media & Consumables
• Biobank Equipment Market, End User:
• Pharmaceutical and Biotechnology Companies
• Medical Device Companies
• Others
• Biobank Equipment Market, By Region:
• North America

o   United States

o   Canada

o   Mexico

• Europe

o   Germany

o   United Kingdom

o   Italy

o   France

o   Spain

• Asia Pacific

o   China

o   India

o   Japan

o   South Korea

o   Australia

• South America

o   Brazil

o   Argentina

o   Colombia

• Middle East & Africa

o   South Africa

o   Saudi Arabia

o   UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biobank Equipment Market.

Available Customizations:

Global Biobank Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Biobank Equipment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]